Venous bleeding during transsphenoidal surgery for resection of pituitary tumors is a common problem that interferes with the performance of the surgical procedure. In this study, data were collected prospectively from 50 patients to determine whether there were preor intraoperative factors (e.g., patient demographics, type and grade of pituitary tumor, intraoperative hemodynamics) associated with venous bleeding which might be used to predict its occurrence. In addition, central venous pressure (CVP), and cavernous sinus pressure (CSP) were measured in 13 patients to evaluate the relationship of these pressures to each other and to the severity of venous bleeding. During resection of the pituitary tumor, the severity of venous bleeding was graded as minimal, moderate, or severe, the latter two grades requiring therapeutic intervention. Moderate bleeding requiring intervention occurred in 15 of the 50 patients, and resolved in all cases. Moderate bleeding was not related to CSP or CVP, and no specific associated factor was observed. CSP was not correlated with CVP, and was higher than that predicted from the CVP and the position of the patient or the hydrostatic gravitational pressure gradient. These results suggest that it is not possible to predict in advance which patients will have problems with venous bleeding, but that simple therapeutic maneuvers are effective.
D
uring the transsphenoidal approach for surgery of the pituitary gland, troublesome venous bleeding may occur from the cavernous sinus (1,2). Data on causative or associated factors for venous bleeding do not exist. It is unclear why venous bleeding occurs, as the position of the patient during surgery (semisitting at an angle of approximately 40") (3,4) predicts that the dural venous sinus pressure should be negative (5,6). Reports of air embolism occurring during transsphenoidal surgery support the existence of negative pressure in the cavernous sinus (7). Despite this prediction of negative venous pressure, venous bleeding occurs commonly during transsphenoidal pituitary surgery (1,2). To better understand the genesis of venous bleeding during transsphenoidal surgery, we attempted to identify preoperative patient characteristics and factors during the intraoperative course that might predict the occurrence of venous bleeding. In addition, we measured the pressures in the central veins and cavernous sinus to examine their relationship to each other and to venous bleeding.
Methods
After approval by our Committee of Human Research, we prospectively collected data from 50 consecutive patients aged 18 yr and older scheduled to undergo transsphenoidal pituitary surgery. Of these 50 patients, 13 gave written informed consent for invasive measurement of cavernous sinus pressure (CSP) and central venous pressure (CVP). All patients had normal coagulation as documented by history and physical examination and by measurement of prothrombin time, partial thromboplastin time, and platelet count.
Patients were premeditated with midazolam, l-2 mg intravenously (IV), and anesthesia was induced with fentanyl, l-3 pg/kg IV and sodium thiopental, 2-5 mg/kg IV. Vecuronium, 0.1 mg/kg IV, or succinylcholine, 1.5 mg/kg IV, was administered to Anesthesia was maintained with isoflurane 0.5%-l% and nitrous oxide 60%-70% (end-tidal concentrations) and supplemented by fentanyl, 50-100 pg IV.
After induction of anesthesia in 13 patients, a central venous catheter (AK-04250; Arrow International, Reading, PA) was inserted via an antecubital vein. All patients were then turned to the left lateral position and a subarachnoid catheter was placed in the lumbar region. Patients were returned supine and positioned for surgery, semisitting at an angle of approximately 40" with the head turned toward the right side (3).
In patients with central venous catheters, the position of the catheter tip was confirmed using the electrocardiogram (8). The catheter was flushed with 2-3 mL of 8.4% sodium bicarbonate solution and the right arm lead of the standard lead II was attached to the electrocardiogram adapter of the catheter. The catheter was advanced toward the sinoatrial node, and as the node was approached, the upright P wave progressively became larger, and at its maximum it was approximately the height of the R wave. The catheter was then withdrawn 2-3 cm, a position just proximal to the junction of the superior vena cava and the right atrium (8). The pressure transducer was zeroed at the level of the right atrium (fourth intercostal space, midaxillary line). The height difference between the cavernous sinus (taken as the level of the midpoint of zygomatic arch) and the right atrium was measured.
In all patients we recorded the preoperative characteristics: age, gender, weight, height, ASA classification, and the type of pituitary lesion including anatomic classification of the pituitary tumor (grade and extension; Table 1) (31, and endocrine function (defined as endocrine-active, i.e., secreting prolactin, growth hormone, and corticotropin, or as endocrine-inactive).
Heart rate and noninvasive systolic (SBP) and diastolic blood pressure (DBP) also were recorded preoperatively and at specific points in the procedure. These points were: before (baseline measurement) and after the injection of lidocaine 0.5% with epinephrine 1:200,000 (submucosally in the nasal septum), during advancement of the self-retaining speculum toward the sphenoid rostrum and, immediately before the dura was incised to permit exposure of the pituitary gland. In patients with central venous catheters, CVP was recorded at the same times. The administration of antihypertensive medications was recorded. After resection of the pituitary tumor, the CSP was measured by inserting a 3.5-in, 27-gauge spinal needle into the cavernous sinus on either side of the pituitary gland. The pressure recording system was zeroed at the level of the cavernous sinus. To confirm the placement of the needle into the cavernous sinus, an appropriate waveform and/or an increase in pressure with compression of the internal jugular vein were observed. CVP was recorded simultaneously with the CSP measurement.
To derive a prediction for the CSP (in mm Hg), the height difference (in cm) from the level of the cavernous sinus to the level of the right atrium was divided by 1.36 and this value was subtracted from the CVP (mm Hg).
The degree of venous bleeding was graded by the surgeon as follows: minimal, little bleeding, not interfering with surgery; moderate, bleeding which interfered with surgery, and required intervention;
severe, significant interference with surgery, and bleeding unresponsive to intervention. For statistical analysis, patients were grouped according to the grading of venous bleeding. Several categories of variables were evaluated for a possible association with venous bleeding. Patient demographics of age, gender, weight, height, and ASA classification, characteristics of the pituitary lesion (grade, extension, and endocrine function), and administration of antihypertensive medication were examined for an association with the degree of venous bleeding by Student's t-test or the Fisher exact test as appropriate. The change of hemodynamic variables (SBP, DBP, heart rate, and CVP) during the operative procedure was examined using repeated measures analysis of variance. or subsequent transsphenoidal surgery had minimum bleeding. There were no significant differences in age, gender, height, weight, ASA classification, the grade or endocrine function of the pituitary lesion, or number of transsphenoidal surgeries between the minimum bleeding and moderate bleeding groups (Table 2 ). For patients with suprasellar extension of the tumor, bleeding was more likely to be minimal (P < 0.05).
Hemodynamic changes during the surgical procedure showed a similar pattern in minimal and moderate bleeding (Fig. 1) . During anesthesia, the baseline values for SBP and DBP were lower than the preoperative value in both minimal and moderate bleeding (P < 0.05). SBP and DBP increased after epinephrine was infiltrated beneath the nasal mucosa in both minimal and moderate bleeding (P < 0.05). Antihypertensive medication was administered to control the epinephrine-induced increase in blood pressure in 10 of 35 patients in the minimum bleeding group and 3 of 15 in the moderate bleeding group (no significant difference). During advancement of the speculum toward the sphenoid rostrum, SBP and DBP increased in both minimum and moderate bleeding groups (P < 0.05), and the magnitude of the change was similar in both groups. At dural incision, SBP and DBP were similar in both the minimum and moderate bleeding groups. The pattern of heart rate changes was similar to that for the blood pressure changes. The number of patients requiring antihypertensive medication at any time during the operative procedure was not different Baseline CVP values were 6 + 3 mm Hg and 7 ? 3 mm Hg, respectively, in the minimum and moderate bleeding groups. In patients with minimum bleeding, CVP did not change during the procedure, whereas in those with moderate bleeding CVP increased by a mean of 2 mm Hg after epinephrine injection and during the advancement of the nasal speculum (P < 0.05), but returned to the baseline level at the time of dural incision.
CSP varied from -17 to 4 mm Hg (median 2 mm Hg) and -7 to 9 mm Hg (median -1 mm Hg), respectively, in the minimal and moderate bleeding groups, a statistically insignificant difference (Fig. 2) . CVP at the time of CSP measurement varied from 0 to 11 mm Hg (median 5 mm Hg) and from 2 to 9 mm Hg (median 8 mm Hg), respectively, in the minimum and moderate bleeding groups (no difference) (Fig. 2) . The height difference between the cavernous sinus and the right atrium showed no difference between the minimum and moderate bleeding groups (24 + 3 mm Hg and 25 2 3 mm Hg, respectively). Except for one patient with minimum bleeding, measured CSP was always higher than the predicted CSP and showed no statistical difference between the minimum and moderate bleeding groups (Fig. 2) . There was no significant correlation between CSP and CVP (Fig. 3) .
At the time when moderate bleeding occurred, both SBP and DBP (121 + 21 and 73 + 21 mm Hg, respectively) were significantly greater (by approximately 8%) than baseline pressures (P < 0.05). CVP at this ANESTHESIA LEE ET AL. time (8 2 4 mm Hg) was also greater (by a mean of 1 mm Hg) than baseline (P < 0.05). Interventions to decrease venous bleeding were: to decrease systemic blood pressure using nitroglycerin infusion (l-10 pg. kg-' . min-i) (four patients), or propofol by bolus injection (three patients); to decrease mean intrathoracic pressure, by changing from mechanical to manual ventilation (six patients). In two patients, both manual ventilation and nitroglycerin infusion were used for control of the bleeding. In all patients in whom it occurred, the moderate bleeding resolved before or during the tumor resection. We found only one preoperative characteristic that was associated with the severity of venous bleeding, namely minimum bleeding and suprasellar extension of the tumor. No preoperative characteristic was specifically associated with the occurrence of moderate venous bleeding.
Intraoperatively, only two factors were associated with moderate bleeding. The first was that at the time moderate venous bleeding was occurring, systemic arterial pressure was approximately 8% greater than the baseline pressure measured before the submucosal injection of epinephrine.
The other factor associated with moderate bleeding was the CVP which, when the bleeding was occurring, was greater (by an average of l-2 nun Hg) than baseline. However, the magnitude of these cardiovascular differences were small and not easily identifiable intraoperatively.
CVP bore little relationship to the CSP. With one exception, the CSP was always greater than predicted from the CVP. In two patients, CSP was greater than the CVP, and was positive in eight patients. This latter finding was unexpected because the significant elevation of the patient's head above the level of the heart would be expected to result in a negative pressure in the intracranial venous sinuses (5,6,9). Pressure in the confluens sinuum reaches zero with 25" elevation of the head, and becomes negative with greater elevation (5,6). A similar result has been found for the pressures in the sagittal sinus (9). However, in this study, the cavernous sinus pressures were variable and often positive. Therefore, other factors in addition to the elevation of the patient's head must have influenced cavernous sinus pressures.
For CVP and CSP to be closely correlated requires a nonobstructed venous connection between the central veins and the cavernous sinus; however, there are several reasons why this may not be the case. First, since some of the venous connections are thin walled and collapsible, they collapse as the head is elevated and may act as a Starling resistor (10). Second, there are valves in the internal jugular venous system which may prevent direct transmission of central venous pressure to the peripheral veins (11). Finally, and potentially of more importance, is the effect of turning the patient's head to the right to obtain the optimal position for surgery.
Extreme rotation of the head (60-80") increases the pressure in the dural venous sinuses, with rightward rotation exerting a greater effect than leftward rotation (5). This increased pressure may be due to compression of the internal jugular veins caused by neck rotation. Direct jugular venous compression increases pressure in the sagittal sinus, and unilateral compression of the right internal jugular vein has a greater effect than unilateral compression of the left internal jugular vein (9). In our patients, the head was rotated only 40" to the right, but this may have been sufficient to produce right internal jugular vein compression in some of the patients, resulting in increased pressure in the cerebral venous system, including the cavernous sinus. Thus, venous obstruction anywhere in the communication between the central veins and cavernous sinus could result in a higher than predicted CSP.
A problem with a study such as this is the issue of statistical power. Because the number of patients was small, 35 with minimum and 15 with moderate bleeding, it was not possible only to detect factors which had a strong association with either outcome. To illustrate this, of the patients who required antihypertensive medication at some point during the study, 16 were in the minimum bleeding and 9 in the moderate bleeding groups. Should the need for antihypertensive medication truly be associated with moderate bleeding, our study had only 7% power to detect this. However, to have 50% power to detect such a difference at the P < 0.05 level would require studying 225 patients, and to have 80% power would require over 2000 patients. We must acknowledge that we may have failed to detect factors having a weak association with moderate bleeding. However, as moderate bleeding resolved in all cases, the issue, from a clinical perspective, is moot.
Another problem was our inability to measure CSP at the time of assessment of the venous bleeding, because the cavernous sinus could only be accessed safely for pressure measurement once the tumor resection was complete, and by this time therapeutic measures had been taken to treat the cases of moderate bleeding. Because in 9 of the 15 cases of moderate bleeding, therapy was directed at reducing systemic arterial pressure, this intervention may have reduced the pressure in the cavernous sinus. This appears likely because three patients with moderate bleeding ANESTHESIA LEE ET AL. Our measurements of CSP varied from -17 to 9 mm Hg. The explanation for such a wide range is likely to be multifactorial.
If there was a direct communication between the central veins and the cavernous sinus then a negative pressure as low as -13 mm Hg would have been predicted in one patient (actual measurement, 17 mm Hg). However, because of the potential for a variable degree of venous obstruction, as discussed above, the observation of a widely variable increase in CSP above the value predicted from the CVP is not surprising.
These findings suggest that measurement of CVP is not useful in the prediction of intraoperative venous bleeding, and that CVP is a poor predictor of CSP.
One of the reasons for performing this study was to attempt to identify patients at risk for venous bleeding, and to determine whether invasive monitors such as central venous catheters were justified in order that their use could be planned prospectively.
Although we could not identify factors useful in the prediction of venous bleeding problems, the fact that in all cases the bleeding resolved suggests that prior identification of patients at risk of bleeding is not necessary. We did not set out to study therapeutic interventions, and because we did not have control group who received no intervention, we cannot conclude whether or not our interventions were responsible for the resolution of the venous bleeding.
In summary, venous bleeding of a degree sufficient to interfere with the performance of the surgical procedure and requiring treatment occurred in 15 of 50 patients undergoing transsphenoidal resection of a pituitary tumor. In patients with suprasellar extension of the tumor, troublesome bleeding was less likely, and this was the only factor associated with bleeding that could be readily identified clinically.
